BOCA RATON, FL / ACCESS Newswire / June 2, 2025 / Greenlane Holdings, Inc. ("Greenlane" or the "Company") (NASDAQ:GNLN), one of the premier global sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, today announced today announced that the Nasdaq Hearings Panel ("Panel") has granted the Company's request for an extension to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market. As previously reported by Greenlane on its current report on Form 8-K, on April 2, 2025, the Listing Qualifications Department (the "Nasdaq Staff") of the Nasdaq Stock Market ("Nasdaq") issued a determination …

OVERLAND PARK, KS / ACCESS Newswire / June 2, 2025 / Tortoise Capital today announced the following unaudited balance sheet information and asset coverage ratio updates for closed-end funds TYG and TEAF. Tortoise Energy Infrastructure Corp. (NYSE:TYG) today announced that as of May 30, 2025, the company's unaudited total assets were approximately $969.2 million and its unaudited net asset value was $772.2 million, or $44.80 per share.

Alibaba (BABA 1.06%), the largest e-commerce and cloud company in China, went public at $68 per share on Sept. 18, 2014. It raised $25 billion, making it the largest IPO in history at the time, and it held that record until Saudi Aramco's $29.4 billion IPO in 2019.

Credo Technology Group Holding Ltd (NASDAQ:CRDO ) Q4 2025 Earnings Conference Call June 2, 2025 5:00 PM ET Company Participants Dan O'Neil - VP, Corporate Development & IR Bill Brennan - CEO Dan Fleming - CFO Conference Call Participants Vivek Arya - Bank of America Securities Tore Svanberg - Stifel Quinn Bolton - Needham & Company Tom O'Malley - Barclays Vijay Rakesh - Mizuho Karl Ackerman - BNP Paribas Suji Desilva - ROTH Capital Christopher Rolland - Susquehanna Joshua Buchalter - TD Cowen Richard Shannon - Craig-Hallum Operator Ladies and gentlemen, thank you for standing by. At this time, all …

TEANECK, N.J. , June 2, 2025 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) has been named Partner of the Year by Pegasystems, Inc., a global leader in enterprise software, at the annual PegaWorld 2025 conference.

NEW YORK CITY, NY / ACCESS Newswire / June 2, 2025 / WHY: New York, N.Y., June 2, 2025.

Lumber is in the spotlight as the National Association of Home Builders and the U.S. Lumber Coalition disagree about what's behind the U.S. housing market experiencing a slump.

Insurance is a $3 trillion market that touches nearly every household, vehicle, and business. It's one of the largest industries on Earth, yet also one of the hardest to disrupt.

Gold edged higher in the early Asian session amid trade and geopolitical tensions, which support safe-haven demand for the precious metal.

Coinbase reportedly knew in January about a data breach at an outsourcing company that it publicly disclosed May 14 in a filing with the Securities and Exchange Commission (SEC).

NEW YORK , June 2, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Open Lending Corporation (NASDAQ: LPRO) between February 24, 2022 and March 31, 2025, both dates inclusive (the "Class Period"), of the important June 30, 2025 lead plaintiff deadline. So what: If you purchased Open Lending securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

RESTON, Va.--(BUSINESS WIRE)-- #LimitlessPotential--CACI International Inc (NYSE: CACI) today announced it closed a $1.0 billion offering of 6.375% unsecured senior notes due in 2033. CACI used proceeds from the notes offering to partially repay amounts outstanding under its revolving credit facility. About CACI At CACI International Inc (NYSE: CACI), our 25,000 talented and dynamic employees are ever vigilant in delivering distinctive expertise and differentiated technology to meet our customers' greatest challenge.

Taipei, Taiwan, June 02, 2025 (GLOBE NEWSWIRE) -- Semilux International Ltd. (NASDAQ:SELX) (“SELX” or the “Company”) announced that it received a delinquency notification letter on May 27, 2025 (the “Deficiency Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (the “Nasdaq”) notifying the Company that it is no longer in compliance with the Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) for continued listing due to its failure to timely file its annual report on Form 20-F for the year ended December 31, 2024 (the “Annual Report”) with the U.S. Securities and Exchange Commission. The Listing Rule requires …

ROCKVILLE, Md. and SUZHOU, China, June 02, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest data from a Phase Ib/II study of the investigational Bcl-2 inhibitor, lisaftoclax (APG-2575), in combination with hypomethylating agent azacitidine in patients with treatment-naïve (TN) or prior venetoclax-exposed myeloid malignancies, in an oral presentation at the 61st American Society of Clinical Oncology (ASCO) Annual Meeting.

BOCA RATON, FL, June 02, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company” or “DeFi Dev Corp.”), the first US public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced a record-setting May 2025 highlighted by significant advancements across its validator infrastructure, treasury growth, and strategic integrations.

ROCKVILLE, Md. and SUZHOU, China, June 02, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest clinical data from its Phase II study of the MDM2-p53 inhibitor alrizomadlin (APG-115) as a single agent or in combination with PD-1 inhibitor toripalimab in patients with advanced adenoid cystic carcinoma (ACC) or other solid tumors in a poster presentation at the 61st American Society of Clinical Oncology (ASCO) Annual Meeting. Alrizomadlin is the first MDM2-p53 inhibitor to enter clinical development in China and …

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Bitfarms Ltd. (NASDAQ:BITF) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bitfarms-ltd-lawsuit-submission-form?prid=151351&wire=1&utm_campaign=30 or contact Joseph E.

Tokyo, Japan and Cambridge, UK, 3 June 202 5 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that its partner, Neurocrine Biosciences (“Neurocrine”) has dosed the first patient in its Phase 3 registrational program of NBI-1117568 (NBI-'568) as a potential treatment for schizophrenia, resulting in a payment of US$15 million to Nxera (Clinical Trial ID: NCT06963034). The US$15 million payment will be fully recognized as revenue in the second quarter of 2025.

Jobs Week reports begin with the JOLTS numbers out Tuesday morning.

Ladder Capital Corp is an investment grade commercial real estate mortgage REIT, ideal for income investors. LADR pays a quarterly dividend that is stable, consistent, and ideal for income investors. Key metrics are smart, where debt is moderate and dividend coverage is strong. The insiders own 11% of the company shares.